Searched for
BINISH CHUDGAR
Intas to provide 2 million hydroxychloroquine tablets for WHO study on COVID-19Intas informed that it is collaborating on the WHO-endorsed study using hydroxychloroquine, a drug that may have an effect in preventing an...30 Mar, 2020, 04.42 PM IST- Siddhartha Lal wins the EY Entrepreneur Of the Year for 2018Lal will now represent India at the EY World Entrepreneur of the Year Award (WEOY) in Monte Carlo from 6 – 8 June 2019.12 Feb, 2019, 10.22 PM IST
- Desi pharma companies top in biosimilars globallyBiosimilars are approved versions of biopharmaceuticals — complex medicines manufactured using live organisms, as against conventional drug...29 Oct, 2018, 10.31 AM IST
- Intas closing in on Mallinckrodt’s US generics businessThis comes as US President Donald Trump has declared opioid addiction a public health emergency in the US and drugmakers have found themsel...08 Nov, 2017, 03.48 PM IST
- ET Awards: Ola's Bhavish Aggarwal wins Entrepreneur award for corporate excellenceBhavish Aggarwal graduated from the Indian Institute of Technology with a degree in computer science. Today, he’s battling Uber, one of the...06 Sep, 2017, 02.01 PM IST
- Intas eyes Teva’s oncology, women’s health divisions in EuropeTeva, the world’s largest maker of generic drugs, plans to divest some assets including its global women’s health and European cancer and p...16 Aug, 2017, 08.44 PM IST
- ChrysCapital sells 3% in Intas to Capital InternationalChrysCapital will continue to hold a 3% stake in Intas, making it the longest and probably the most successful private equity investment in...03 Apr, 2017, 12.33 PM IST
- Chudgars of Intas: A family that dreams big togetherTrumping bigger rivals Aurobindo, Intas shot into the limelight on Wednesday, scooping up Teva's assets in the UK and Ireland in a $764 mil...07 Oct, 2016, 10.57 AM IST
- Intas buys Teva's UK & Ireland assets for $764 million to break into global top 20 generic players clubWith the acquisition of Teva’s products, sold through erstwhile Actavis’ operations, Intas is set to emerge as a top player in the UK gener...06 Oct, 2016, 05.52 PM IST
- Intas Pharmaceuticals to launch its first biosimilar in US in 9-12 monthsIntas is the only domestic firm with two biosimilars filed for registration in the US and it looks to deliver affordable and innovative pha...21 Jun, 2015, 01.54 PM IST
- Intas Pharma launches its first biosimilar product Accofil in EuropeThe product has recently been introduced under the brand Accofil and has already won two prestigious tenders, in Netherlands and the UK.23 Feb, 2015, 02.51 PM IST
- Intas Pharmaceuticals sells ChrysCapital’s stake to TemasekIntas Pharmaceuticals Ltd has announced that Singapore investment company Temasek has acquired a 10.16% equity stake in the company.11 Nov, 2014, 01.00 PM IST
- Temasek completes 10.16% stake purchase in Intas PharmaTemasek acquired the stake by way of secondary purchase of shares from private equity investor ChrysCapital. This investment will deepen Te...10 Nov, 2014, 05.29 PM IST
- Open to acquisition, can spend up to $100 million: Binish Chudgar, Intas PharmaceuticalsIntas Pharmaceuticals is not ignoring the local market where it plans to be among the top five players by 2015, vice-chairman and MD Binish...01 May, 2012, 04.52 AM IST
- ChrysCap to buy Rs 300-cr stake in Intas PharmaceuticalsPrivate equity firm ChrysCapital is buying an additional stake in Intas Pharmaceuticals for Rs 300 crore after the Ahmedabad-based drug mak...26 Apr, 2012, 01.16 AM IST
- ChrysCapital set to raise stake in Intas Pharmaceuticals ahead of deferred IPOAlthough the stake could not be be confirmed, the pre-IPO deal will increase ChrysCapital's holding in the company to over 15% from 11.3% c...25 Apr, 2012, 03.12 PM IST
- Intas Pharma IPO to raise Rs 800 cr, fund acquisitionsIntas Pharma plans to raise Rs 750-800 cr through IPO that will help it raise fresh funds for acquisitions besides allowing PE investor Chr...06 Sep, 2010, 03.47 AM IST
Load More
